PODIAPP
LIVE

Serial Number

79246181

Owner

PODARTE S.R.L.

Attorney

John Pickerill

Filing Date

Sep 5, 2018

Add to watchlist:

No watchlists yet
View on USPTO

PODIAPP Trademark

Serial Number: 79246181 • Registration: 6039117

PODIAPP is a trademark filed by PODARTE S.R.L. on September 5, 2018. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

PODARTE S.R.L.

Via Salvo D'Acquisto, n. 26

Entity Type: 99

Trademark Details

Filing Date

September 5, 2018

Registration Date

April 28, 2020

Published for Opposition

February 11, 2020

Goods & Services

Training in the field of treatment of diabetes patients and diabetes symptoms; medical training and teaching; training in the field of medicine; organization of symposia in the field of medical science for educational purposes; organization of seminars in the field of medical and medical technician training; organization of training in the field of healthcare; advice relating to medical training; educational services in the healthcare sector, namely, conducting classes, seminars, conferences, and workshops in the field of healthcare; organization of seminars and conventions in the field of medicine for educational purposes

Downloadable software applications for use in database management for storing treatment information in the field of diabetes; educational software featuring instruction in diabetic foot management; downloadable computer application software for use in monitoring, diagnosing, managing and treating symptoms and maladies resulting from diabetes; computer application software for mobile phones and handheld computers, namely, software containing an algorithm that allows users to monitor, manage and assess risk levels for diabetes patients; bioinformatics software, namely, software for collecting, storing, and analyzing biochemical and biological data; downloadable mobile software for use in monitoring, diagnosing, managing and treating symptoms and maladies resulting from diabetes; application software for mobile devices, namely, software for use in monitoring, diagnosing, managing and treating symptoms and maladies resulting from diabetes; downloadable application software for smart phones, namely, software for use in monitoring, diagnosing, managing and treating symptoms and maladies resulting from diabetes

Medical services; medical advisory services relating to medical services; medical advisory services relating to medical problems; medical services in the field of diabetes; medical health assessment services; provision of medical services

Biological research, clinical research in the field of treatment of symptoms and maladies associated with diabetes and in the field of orthotic therapy and medical research; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; medical research laboratory services; analysis of human tissues for medical research; scientific research for medical purposes; development of pharmaceutical preparations and medicines; providing scientific information in the field of medical disorders and their treatment; design services, namely, computer-aided product design for creating custom orthotic products; quality checking and testing, namely, quality control for others; material testing; product safety testing; rental of computer software; installation of computer software; software creation; application service provider (ASP), namely, hosting computer software applications of others; rental of application software

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Apr 28, 2025 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Nov 3, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 26, 2020 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Sep 8, 2020 FICS
FINAL DISPOSITION PROCESSED
Sep 5, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Jul 28, 2020 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 8, 2020 OPNX
REGISTERED-PRINCIPAL REGISTER
Apr 28, 2020 R.PR
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 22, 2020 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 22, 2020 OPNR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 11, 2020 NPUB
PUBLISHED FOR OPPOSITION
Feb 11, 2020 PUBO
NOTIFICATION PROCESSED BY IB
Feb 7, 2020 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 22, 2020 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Jan 22, 2020 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 22, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 7, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 30, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 30, 2019 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 30, 2019 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
Jul 18, 2019 GNFN
FINAL REFUSAL E-MAILED
Jul 18, 2019 GNFR
FINAL REFUSAL WRITTEN
Jul 18, 2019 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 27, 2019 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 27, 2019 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 27, 2019 TROA
REFUSAL PROCESSED BY IB
Jan 25, 2019 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 7, 2019 RFCS
REFUSAL PROCESSED BY MPU
Jan 7, 2019 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 21, 2018 RFCR
NON-FINAL ACTION WRITTEN
Dec 20, 2018 CNRT
ASSIGNED TO EXAMINER
Dec 15, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 30, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 26, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 22, 2018 REPR